125 related articles for article (PubMed ID: 22126980)
1. Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis.
Novak J; Julian BA
Kidney Int; 2011 Dec; 80(12):1252-4. PubMed ID: 22126980
[TBL] [Abstract][Full Text] [Related]
2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
3. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
4. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
5. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
[TBL] [Abstract][Full Text] [Related]
6. Primary IgA nephropathy: new insights into pathogenesis.
Barratt J; Feehally J
Semin Nephrol; 2011 Jul; 31(4):349-60. PubMed ID: 21839368
[TBL] [Abstract][Full Text] [Related]
7. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
8. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
Grossetête B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
[TBL] [Abstract][Full Text] [Related]
10. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
Barratt J; Smith AC; Feehally J
Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
[TBL] [Abstract][Full Text] [Related]
14. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
15. Role of macromolecular IgA in IgA nephropathy.
van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy.
Jhee JH; Kang HY; Wu M; Nam BY; Chang TI; Jung SY; Park S; Kim H; Yun HR; Kee YK; Yoon CY; Park JT; Yoo TH; Kang SW; Han SH
Clin Chem Lab Med; 2017 Nov; 56(1):75-85. PubMed ID: 28672768
[TBL] [Abstract][Full Text] [Related]
17. Circulating Fc-receptor blocking factors in IgA nephropathies.
Roccatello D; Coppo R; Piccoli G; Cordonnier D; Martina G; Rollino C; Picciotto G; Sena LM; Amoroso A
Clin Nephrol; 1985 Apr; 23(4):159-68. PubMed ID: 3874036
[TBL] [Abstract][Full Text] [Related]
18. IgA, glomerulonephritis and liver disease.
Woodroffe AJ
Aust N Z J Med; 1981; 11(Suppl 1):109-11. PubMed ID: 6942798
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy enigma.
Mestecky J; Novak J; Moldoveanu Z; Raska M
Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
[TBL] [Abstract][Full Text] [Related]
20. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]